Another independent group also showed that PD-1+ TIGIT+ CD8+ T cells with low expression levels of DNAM-1 (DNAX accessory molecule 1 or CD226) represent dysfunctional T cells [108], further providing evidence that TIGIT represents a key checkpoint molecule in AML. This evidence concerns the gene CD8A and acute myeloid leukemia.